General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

American Depository Shares (ADS)

Since May 11, 2000, Novartis shares also have been available in the form of American Depositary Shares (ADSs) traded on the New York Stock Exchange. Novartis ADSs are listed on the New York Stock Exchange under the trading symbol "NVS" at prices quoted in US dollars.

Novartis no longer provides a direct share purchase plan. For information regarding purchase of Novartis ADRs through JPMorgan Chase's Global Invest Direct Plan, please call toll-free: 1-(800) 428-4237.


Stock chart